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THE effect of prostaglandtn Ez, iloprost and cAMP
on both nitric oxide and mmour necrosis factor-
release in J774 macrophages has been studied.
Both prostaglandin Ez and tloprost inhibited, in a
concentration-dependent fashion, the lipopoly-
saccharide-tnduced generation of nitric oxide and
mmour necrosis factor-. The inhibitory effect of
these prostanoids seems to be mediated by an
increase of the second messenger cAMP since it
was mimicked by dibutyryl c2iMP and potentiated
by the selective type IV phosphodiesterase inhi-
bitor RO-20-1724. Our results suggest that the
inhibition of nitric oxide release by pros-
taglandtn E2 and iloprost in lipopolysaccharide-
activated J774 macrophages may be secondary to
the inhibition of tumour necrosis factor- genera-
tion, which in turn is likely to be mediated by
cAMP.
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Introduction
Macrophages activated with bacterial lipopoly-
saccharide release a variety of mediators includ-
ing nitric oxide (NO), tumour necrosis factor
(TNF-a) and prostaglandins, namely pros-
taglandin E2 (PGE2) and prostacyclin (PGI2).1-3
The cytotoxic properties of activated macro-
phages depend, at least in part, on the biological
activities of these mediators. Thus the synthesis
of NO from the amino acid t-arginine has been
shown to be a major cytotoxic mechanism of
activated macrophages.
1 Moreover NO has been
identified as an effector molecule of the cytotoxic
effects produced by TNF-ot in bovine endothelial
cells.4 Conversely, PGE2 and PGI2 inhibit the
cytotoxic properties of activated macrophages.
3
Furthermore, increasing evidence suggests that
the interaction existing within the biological
actions of NO, prostaglandins and TNF-ot may
result in a mutual regulation of their synthesis
and/or release. In fact TNF-a has been reported
to induce NO synthase in murine peritoneal mac-
rophages5 and bovine endothelial cells.4 TNF-cg
increases PGE2 production in human synovial
6 cells and human dermal fibroblasts, mouse peri-
7 8 toneal macrophages and rat Kupffer cells, as
well as PGb generation in human endothelial
cells.9 Conversely, PGE2 has been shown to
down-regulate the generation of TNF- in macro-
phages of different origini’m and HL-60 cells.
1
Moreover it has been reported that the release of
TNF-0t by macrophages is inhibited by cAMP, a
second messenger for both PGE2 and PGI2.1-2
We have shown that PGE2 and the stable ana-
logue of PGI2, iloprost, inhibited the induction of
NO synthase in lipopolysaccharide-activated J774
murine macrophages.13 We hypothesized that the
inhibition of NO synthase induction could be
secondary to an increase in cAMP levels in the
activated macrophages. This hypothesis was also
supported by the inability of both prostaglandin
F2= (PGF2) and the stable analogue of throm-
boxane A2 (TXA2), U46619, which do not
enhance cAMP levels, to modify NO generation.
However, since TNF-0t induces No synthase in
murine macrophages
7 and PGE2 has been shown
to inhibit TNF-0t release from these cells,
2 the
inhibition of NO synthase induction by PGE2
could also be secondary to the down-regulation
of TNF-a in J774 cells.
In the light of the above considerations we
have studied the effect of PGE2, PGI2 and cAMP
on the production of NO and TNF-a by lipopoly-
saccharide-stimulated J774 macrophages.
Materials and Methods
The murine monocyte macrophage cell line
J774 (American Tissue Culture Catalogue TIB 67,
page 231) was grown in Dulbecco’s modified
Eagle’s medium (Gibco) at 37C as described
previously.
3 The cells were plated in 24-well
culture plates (Falcon) at a density of 2.5 x 105
cells/ml and allowed to adhere at 37C in 5%
COz/95% air for 2h. Thereafter the medium was
replaced with fresh medium, cells were activated
with lipopolysaccharide (0.1 I.tg/ml) from Salmo-
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100- nella thyphosa (Difco) and incubated in the pre-
sence of various concentrations (see Results) of
test compounds: PGE2, PGF20t and dibutyryl
cAMP (Sigma), iloprost (Schering), RO-201724
(Biomol).
NO was measured as nitrites (NO2-, nmol per
10 cells) accumulated in the incubation media o
s0-
24h after lipopolysaccharide challenge. A spect-
rophotometric assay based on the Griess reaction o
was used.
14 . 2s-
The level of TNF<z (U/ml) in the cell medium,
3h after lipopolysacchafide challenge, was as-
sessed in WEHI-164 cells by a biological assay 0
using recombinant human TNF-cz (Sigma) as
reference standard and rabbit antimurine TNF<z
(Genzyme) antiserum which cross-reacts with rat







FIG. 1. Effect of prostaglandin E2 (PGE2), iloprost and dibutyryl
cAMP (dBcAMP) on NO2- generation by J774 murine macro- Data are expressed as percent of control phages 24h after lipopolysaccharide challenge (0.1 lg/ml) in
release (mean standard error of the mean of the absence (open bars) or presence (hatched bars) of RO-
n obscrvations). Comparisons wcrc madc by thc 201724 10-4M. Data are expressed as mean + standard error
of the mean of five to six experiments. **p < 0.01 vs. control unpaired two-tailed Student’s t-test. The level of (lipopolysaccharide alone 100% release); p < 0.05, OOp <
st3tisticaJly significant diffcrcncc was dcfincd as p O.Ol vs. the corresponding concentration of the inhibitor in the
< 0.05. absence of RO-201724.
Results PGE2 and iloprost on NO2-generation (Fig. 1).
The production of NO2-by unstimulated J774 RO-201724 alone (10-4M) did not produce any
macrophages was undetectable (< 1 nmol per effect (data not shown).
106 cells in 24h, n 6). The cells stimulated We have also studied the effect of PGE2, PGI2
with lipopolysaccharide (0.1 tg/ml) released, as (iloprost) and cAMP (dibutyryl cAMP) on TNF-cz
previously reported (Marotta et al.13), substantial release from lipopolysaccharide-activated J774
amounts of NO, measured as NO2- (64.5 +__ 2.3 cells. Three h after lipopolysaccharide-challenge
nmol per 106 cells in 24h, n--8). When the these cells released 297 20.5 U/ml of TNF-cz
cells were stimulated in the presence of dibutyryl (n 8), compared to the undetectable release
cAMP (10-4- 10-6M), PGE2 (10-6- 10-8M) or by unstimulated cells (< 1 U/ml in 3h, n 8).
iloprost (10-7- 10-9M), added concomitantly Both PGE2 (10
-6 10-SM) and iloprost
with LPS, a concentration-dependent decrease of (10-7 10
-12 M) produced a concentration-
NO2- accumulation was observed (Fig. 1). PGE2, dependent inhibition of TNF-ot release (Fig. 2).
iloprost and cAMP, at any of the concentrations PGF2 (10-6 10-SM) did not produce any
tested, did not affect NO2- generation when effect (data not shown). It is interesting to note
added to the cells 6 h after lipopolysaccharide that iloprost, as observed for NO2-generation,
challenge (data not shown). Conversely, PGFi0t was more potent than PGE2, also an inhibitor of
(10-6 10
--8M) did not significantly affect NO2- TNF-{x release. Moreover, both prostanoids sig-
accumulation when added concomitantly with nificantly inhibited (p < 0.01) TNF-cz release at
lipopolysaccharide or 6 h later (data not shown), concentrations which were virtually ineffective on
The inhibition produced by 10-4M dibutyryl NO2-production (10--8M PGE2 or 10-9M ilo-
cAMP was about 50% (p < 0.01) and was vir- prost). The phosphodiesterase inhibitor RO-
really superimposable on the inhibition pro- 201724 (10-4M) potentiated the effect of iloprost
duced by 10-6M PGE2 and 10-7M iloprost. The for significant inhibition (p < 0.01) of TNF-cz
selective inhibitor of cAMP-specific phosphodies- release was observed at concentrations of 10
-1
16 < terase type IV, RO-201724, significandy (p and 10-12M, (10.5 +__ 1.1% and 41.1 +_ 3.7% of
0.01) increased the inhibition induced b.y dibu- control release, respectively; n- 4). Dibutyryl
tyryl cAMP. In fact, in the presence of 10 M RO- cAMP (10
-4 10--6M) inhibited lipopolysacchar-
201724, the inhibition of NO2-accumulation by ide-induced TNF-0t release in a concentration-
10-4M dibutylT1 cAMP was significandy increased dependent fashion (Fig. 2). Moreover, as
from about 50% to about 70% (Fig. l). RO- observed for PGE2 and iloprost, dibutyryl cAMP
201724 also potentiated the inhibitory action of was more potent as an inhibitor of TNF-cz release








FIG. 2. Effect of prostaglandin E2 (PGE2, open bars)iloprost
(hatched bars) and dibutyryl cAMP (dBcAMP, cross-hatched bars)
on TNF- release by J774 murine macrophages 3 h after lipopo-
lysaccharide challenge (0.1 Ig/ml). Data are expressed as mean
+__ standard error of the mean of five to six experiments. *p <
0.05, **p < 0.01 vs. control (lipopolysaccharide alone 100%
release).
than as an inhibitor of NO2-generation, since at
a concentration of 10-5M, which was poorly
effective for NO2- accumulation, a significant
inhibition (p < 0.01) of TNF-0t release was pro-
duced.
Discussion
We have shown that PGE2 and PG12, and its
stable analogue iloprost, which are known to
activate adenylate cyclase, inhibit the induction of
NO synthase in lipopolysaccharide-activated J774
macrophages. We also demonstrated that this
action was not shared by PGF2= and the stable
analogue of TXA2, U46619, which do not
enhance cAMP levels. The results of the present
study show that cAMP, as its permeable form
dibutytryl cAMP, inhibits lipopolysaccharide-
induced NO release by J774 macrophages, and
confirm that this release is inhibited by PGE2 and
iloprost but not by PGF2=. The selective type
IV phosphodiesterase inhibitor, RO-201724,16
potentiated not only the inhibitory effect of
cAMP but also the effect of the two prostanoids.
In the light of these findings our results strongly
suggest that the inhibitory action of the two
prostanoids on NO synthase induction in lipopo-
lysaccharide-activated J774 macrophages is medi-
ated by cAMP. This evidence is also supported
by recent results showing that in murine perito-
neal macrophages, cAMP is an intermediate in
the down-regulation of NO synthase by pros-
taglandins.
7
Our results also show that PGE2 and iloprost,
but not PGF2=, inhibit in a concentration-depen-
dent fashion of lipopolysaccharide-induced TNF-
z production by J774 macrophages. This effect
was exhibited also by cAMP. The phosphodies-
terase inhibitor RO-201724 potentiated this
action. PGF2z was unable to inhibit lipopoly-
saccharide-induced TNF-0t release by J774 macro-
phages. These data suggest that, as obseeced for
NO generation, the inhibitory action of the two
prostanoids on TNF-cz release is likely to be
mediated by cAMP. In this respect it is interesting
to note that all the tested compounds were more
potent in inhibiting TNF-cz than NO2- production.
Since NO seems to be the effector molecule of
the cytotoxic activity of TNF-0t,
5 and PGE2 and
iloprost modulate the production of TNF-cz and
NO,
17 it could be hypothesized that the inhibi-
tory action of the two prostanoids on NO syn-
thase induction might be secondary to the
inhibition of TNF-0t generation which seems to
be mediated by cAMP. This hypothesis appears
conceivable considering that in macrophages
lipopolysaccharide stimulates not only TNF-cz and
NO but also a sustained production of the
prostaglandins, following the expression of indu-
cible cyclooxygenase. In this light the down-
regulation of TNF-a and consequendy of NO
production by endogenous prostaglandins may
represent a relevant feed-back mechanism in
modulating the cytotoxic effects of a sustained
NO production following immunological stimula-
tion.
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